Method for Treatment of lymphoproliferative malignancy continues to administer a single daily dose of compound N - (3 - [(3 - {[2 - Chloro - 5 - (methoxy) phenyl] amino} - 2 quinoxalin - il) amino] sulfonyl] phenyl) - 2 - metilalaninamida.
Methods are provided for treating a lymphoproliferative malignancy to a patient in need of such treatment, comprising administering to the patient an effective amount of compound A as described herein.USO DE N-(3-{[(3-{[2-CLORO-5-(METOXI)FENIL]AMINO}QUINOXALIN-2-IL)AMINO]SULFONIL}FENIL)-2-METILALANINAMIDA, UN TAUTÓMERO, ZWITTERIÓN O SAL DEL MISMO PARA PREPARAR UN MEDICAMENTO ÚTIL EN EL TRATAMIENTO DE UNA NEOPLASIA LINFOPROLIFERATIVA EN UN PACIENTE HUMANO.